Related Experiment Videos
Ischemic encephalopathy in ANA-negative systemic lupus erythematosus
L Emmi1, M Bertoni, G P Marconi
1Department of Allergology and Clinical Immunology, University of Florence, Italy.
Clinical and Experimental Rheumatology
|May 1, 1991
Summary
Systemic lupus erythematosus (SLE) can present with neurological issues and widespread brain lesions, even with mild symptoms. Early detection of anti-Ro/SSA antibodies is crucial for accurate SLE diagnosis.
Area of Science:
- Neurology
- Immunology
- Radiology
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disease with diverse clinical manifestations.
- Neurological involvement in SLE can range from mild symptoms to severe neurological deficits.
- Raynaud's phenomenon and photodermatitis are common dermatological signs associated with SLE.
Observation:
- A patient with a history of Raynaud's phenomenon developed photodermatitis and acute neurological syndrome.
- The neurological syndrome presented with transient focal disorders and extensive, persistent cerebral lesions on imaging (CT, NMR, SPECT).
- A discrepancy was noted between the patient's relatively mild neurological symptoms and the widespread brain abnormalities.
Findings:
- Detection of anti-Ro/SSA antibodies prompted a reconsideration of the diagnosis towards SLE.
- Neuroimaging revealed significant cerebral lesions, suggesting a potential for subclinical neurological damage in SLE.
- Differential diagnosis considered Sneddon's syndrome and multiple sclerosis due to overlapping clinical and imaging findings.
Implications:
- Neuroimaging (CT, NMR, SPECT) may be valuable in SLE patients with even subtle neurological signs to detect underlying brain alterations.
- Identifying anti-Ro/SSA antibodies aids in the diagnosis of neurological SLE.
- Understanding the differential diagnosis is essential for appropriate management of complex neurological presentations in SLE.